Intelligent Bio Solutions Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for INBS, updated each market day.
INBS AI Sentiment
AI predicts Intelligent Bio Solutions Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: Sept. 1, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Intelligent Bio Solutions Inc. Common Stock
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.
Sector
Exchange
Market Cap
$6,872,356
Cap Tier
Employees
60
Headquarters
NEW YORK, NY
Listed Since
Dec. 23, 2020
Website
INBS Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INBS Volatility
Intelligent Bio Solutions Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
